Introduction
To investigate the protective effect of sevoflurane preconditioning on renal ischemia‐reperfusion injury (renalischemiareperfusionmodel, RIRI) and its related mechanism.
Methods
Eighty healthy adult male SD rats were randomly divided into control group (Sham group), model group (RIRI group), sevoflurane pretreatment group (Sev group) and TRPM7 inhibitor combined with sevoflurane pretreatment group (T + Sev group), 20 animals in each group. Hematoxylin‐eosin (HE) staining was used to observe the pathological changes of renal tissue, and the levels of creatinine and urea nitrogen in each group were detected. Deoxyribonucleic acid terminal transferase‐mediated dUTP nick end labeling (TUNEL) assay was used to detect renal cell apoptosis, and Western blottingwas used to detect the expression of apoptotic proteins cleaved‐caspase‐3, bax, Bcl‐2, and TRPM7 in renal tissue; Detection of oxidative stress‐related index levels in renal tissue and levels of inflammatory factors in renal tissue and serum.
Results
Compared with the Sham group, the renal tissue pathological damage was aggravated, the levels of creatinine and blood urea nitrogen were increased, and the apoptosis was increased in the RIR group and the Sev group. Death, malondialdehyde (MDA) levels and inflammatory factors were increased, and superoxide dismutase (SOD) levels were decreased (all
p
< .05); The scores, apoptosis rate, MDA level, and relative expression of inflammatory factor levels were decreased, and SOD levels were increased (all
p
< .05). Compared with the Sev group, the renal tissue pathological damage in the T + Sev group was aggravated, creatinine, blood urea nitrogen levels increased, apoptosis increased, apoptosis‐related proteins cleaved‐caspase‐3, bax, Bcl‐2 showed increased apoptosis, malondialdehyde (MDA) levels, inflammatory factor levels increased, ultrahigh The levels of oxide dismutase (SOD) were decreased (all
p
< .05).
Conclusions
Therefore, we believe that sevoflurane is involved in the protection of rat renal ischemia‐reperfusion injury by downregulating the expression of TRPM7.